Background: Impaired glucose tolerance (IGT) in patients with ischemic stroke can return to normal, reflecting an acute stress response, or persist. Persistent IGT is associated with an increased risk of recurrent stroke, other cardiovascular diseases and unfavorable outcome after stroke. We aim to validate our previously developed model to identify patients at risk of persistent IGT in an independent data set, and, if necessary, update the model. Methods: The validation data set consisted of 239 nondiabetic patients with a minor ischemic stroke or TIA and IGT in the acute phase (2-hour post-load glucose levels between 7.8 and 11.0 mmol/l). The outcome was persistent versus normalized IGT, based on repeated oral glucose tolerance test after a median of 46 days. The discriminative ability of the original model was assessed with the area under the ROC curve (AUC). The updated model was internally validated with bootstrap resampling and cross-validated in the development population of the original model. Results: One-hundred eighteen of 239 (49%) patients had persistent IGT. The original model, with the predictors age, current smoking, statin use, triglyceride, hypertension, history of cardiovascular diseases, body mass index (BMI), fasting plasma glucose performed poorly (AUC .60). The newly developed model included only BMI, hypertension, statin use, atrial fibrillation, 2-hour post-load glucose levels, HbA1c, large artery atherosclerosis, and predicted persistent IGT more accurately (internally validated AUC 0.66, externally validated AUC .71). Conclusions: This prediction model with simple clinical variables can be used to predict persistent IGT in patients with IGT directly after minor stroke or TIA, and may be useful to optimize secondary prevention by early identification of patients with disturbed glucose metabolism.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Stroke and Cerebrovascular Diseases
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Abnormal glucose metabolism in non-diabetic patients presenting with an acute stroke: Prospective study and systematic review.Qjm. 2010; 103: 495-503
- Persistence and predictors of abnormal glucose metabolisms in patients after acute stroke.Neurol Res. 2010; 32: 359-365
- Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus.Qjm. 2005; 98: 871-878
- Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.J Stroke Cerebrovasc Dis. 2014; 23: 1669-1675
- Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke.Stroke. 2006; 37: 1413-1417
- Effect of pre-diabetes on future risk of stroke: meta-analysis.Bmj. 2012; 344: e3564
- Impaired glucose tolerance is a risk factor for stroke in a Japanese sample-the Funagata study.Metabolism. 2008; 57: 333-338
- Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke: data from abnormal glucose regulation in Patients with acute stroke across China.Stroke. 2014; 45: 1498-1500
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke. 1993; 24: 35-41
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.Diabetes Care. 2020; 43: S14-S31
- Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models.Circulation. 2007; 115: 654-657
- Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients.Stroke. 2009; 40: 1289-1295
- Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: Results from the diabetes prevention program outcomes study.Diabetes Care. 2014; 37: 2622-2631
- Phenotypes of prediabetes and stratification of cardiometabolic risk.Lancet Diabetes Endocrinol. 2016; 4: 789-798
- Progression from newly acquired impaired fasting glusose to Type 2 diabetes.Diabetes Care. 2007; 30: 228-233
- Triglycerides and cardiovascular disease.Lancet. 2014; 384: 626-635
- Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.Cerebrovasc Dis. 2013; 36: 283-289
- Long-term sustainability of diabetes prevention approaches: A systematic review and meta-analysis of randomized clinical trials.JAMA Intern Med. 2017; 177: 1808-1817
- Prediabetes: a high-risk state for diabetes development.Lancet. 2012; 379: 2279-2290
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria.Lancet. 1999; 354: 617-621
- Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.Eur Heart J. 2004; 25: 1990-1997
- Glucose in prediabetic and diabetic range and outcome after stroke.Acta Neurol Scand. 2017; 135: 170-175
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.N Engl J Med. 2016; 374: 1321-1331
- Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.Trials. 2015; 16: 1-6
Published online: April 14, 2020
Accepted: March 13, 2020
Received in revised form: March 7, 2020
Received: February 14, 2020
Grant Support: None.
© 2020 Elsevier Inc. All rights reserved.